Recent studies suggested JAK2 V617F mutation as a risk factor in the pathogenesis of SVT in general population [9,11] albeit JAK2 gene mutation as a prothrombic risk factor in renal transplant recipients is yet to be defined. Here, JAK2 is linked to Supraventricular tachycardia.